Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-042169

Chief Operating Officer sold 10,435 shares at an average $13.06 ($136,263)

  • Chief Operating Officer acquired 10,435 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Capponi Vincent Chief Operating Officer 2018-08-02 Option exercise +2,835 $3.45 $9,781 335,603 D: show line 1 in the form
Capponi Vincent Chief Operating Officer 2018-08-02 Sale −2,835 $13.00 $36,855 332,768 D: show line 2 in the form
Capponi Vincent Chief Operating Officer 2018-08-03 Option exercise +7,600 $3.45 $26,220 340,368 D: show line 3 in the form
Capponi Vincent Chief Operating Officer 2018-08-03 Sale −7,600 $13.08 $99,408 332,768 D: show line 4 in the form
Open-market sales · 10,435 sh · avg $13.06 · $136,263

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Capponi Vincent Chief Operating Officer 2018-08-02 Option exercise · Stock Option (right to buy) −2,835 58,465 D: show line 5 in the form
Capponi Vincent Chief Operating Officer 2018-08-03 Option exercise · Stock Option (right to buy) −7,600 50,865 D: show line 6 in the form
Loading xslF345X03/tv500216_4.xml…